Search Login Register

Pentylenetetrazole (Metrazol) Summary

Description: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.

Also Known As: Metrazol; Pentylenetetrazol; Cardiazol; Corasol; Corazol Show All >>

Networked: 3409 relevant articles (221 outcomes, 472 trials/studies) for this Bio-Agent

Key Diseases for which Pentylenetetrazole is Relevant

  1. Seizures (Seizure) : 212 outcomes 416 studies in 3040 results
  2. Absence Epilepsy (Absence Seizure) : 5 outcomes 3 studies in 30 results
  3. Epilepsy (Aura) : 4 outcomes 39 studies in 218 results
  4. Status Epilepticus (Complex Partial Status Epilepticus) : 2 outcomes 14 studies in 57 results
  5. Schizophrenia (Dementia Praecox) : 2 outcomes 1 study in 8 results
Show All >>

Drugs Related to Pentylenetetrazole

  1. Diazepam (Valium)
  2. Picrotoxin
  3. Bicuculline
  4. Valproic Acid (Valproate, Semisodium)
  5. Strychnine
  6. N-Methylaspartate (NMDA)
  7. gamma-Aminobutyric Acid (GABA)
  8. Phenobarbital (Luminal)
  9. Kainic Acid (Kainate)
  10. Pentylenetetrazole (Metrazol)
Show All >>

Therapies Related to Pentylenetetrazole

  1. Intravenous Infusions
  2. Oral Administration
  3. Injections
  4. Subcutaneous Injections
  5. Ketogenic Diet
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.